APR 17, 2020 9:15 PM PDT

Overcoming Multi-Drug Resistance in Cancer

WRITTEN BY: Nouran Amin

Resistance to chemotherapeutic use in caner patients is something that is inevitable. Continued resistance to these drugs results in poor prognosis and reduced survival rates.

For the past 35 years, scientists have been aiming to overcome multidrug resistance in cancer through a variety of experimental drugs. Some studies were successful in indicating that blocking the expression of certain genes can fight off tumor resistance to chemotherapeutics. However, that particular strategy has been warned to avoid according to a new research study carried by Scripps Research in Florida.

"With the help of our collaborators at New York University Medical Center, we looked at mouse immune cells from five major lymphoid and nonlymphoid tissues: bone marrow, thymus, spleen, lung, and small intestine," says lead author Mark Sundrud, PhD, associate professor of Immunology and Microbiology at Scripps Research. "It became clear that the types of cells that are key to fighting infections and cancers, are among those most sensitive to blocking MDR1 function."

Learn more about the role of the immune-system in fighting off cancer:

The study indicated that blocking the activity of a key gene, multidrug resistance-1 (MDR1), can hold negative effects on the immune system. These effects target the specialized immune cells called CD8+ cytotoxic T lymphocytes (CTLs).

“These insights become all the more pertinent today, given all the questions and concerns related to immunity against the pandemic coronavirus that causes COVID-19," Sundrud says.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 11, 2020
Drug Discovery & Development
APR 11, 2020
Remdesivir Improves COVID-19 Symptoms in 68% of Patients in Early Study
An early analysis of remdesivir, a drug developed by pharmaceutical firm Gilead, has shown that it may have improved sev ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Teenage Cannabis Use May Prime the Brain to Enjoy Cocaine
New research has found that teenage cannabis use may make the brain more susceptible to the effects of cocaine. "It ...
MAY 03, 2020
Drug Discovery & Development
MAY 03, 2020
Hydroxychloroquine: The Controversial Use
COVID-19 was declared a public health threat on January 30th and since then it took the world by a storm with more than ...
MAY 18, 2020
Cancer
MAY 18, 2020
How do Ohnologs affect Cancer?
Genetics can be complicated to say the least. Sometimes it can be as simple as a single mutation in one gene that causes ...
MAY 23, 2020
Cancer
MAY 23, 2020
A New Biomarker to Identify a Triple Negative Breast Cancer Prognosis
Breast cancer, one of the most common cancers in the world, are commonly separated into one of several sub-types. These ...
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
Approved Treatment for RET-mutant Cancers
A drug was recently approved for treating three types of RET-mutant cancers: 1) non-small cell lung cancer (NSCLC) 2) ad ...
Loading Comments...